Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Ebola and Marburg
Gary P. Kobinger
, Maria Croyle
, Heinz Feldmann
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ebola and Marburg'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ebola Virus
100%
Marburg
100%
Ebola
100%
Marburg Virus
66%
Filovirus
33%
Pre-exposure
33%
Democratic Republic of Congo
33%
Preventive Vaccine
16%
Immunology
16%
Vaccine Antigen
16%
Vaccine Candidate
16%
Case Fatality Rate
16%
Hemorrhagic Fever
16%
Highly Pathogenic
16%
Antiviral Vaccines
16%
Nonhuman Primate
16%
New Antivirals
16%
Vaccine Platform
16%
Protective Efficacy
16%
Human Primates
16%
Angola
16%
Phase I Clinical Trial
16%
Filovirus Vaccine
16%
Filoviridae
16%
Weapon Programs
16%
Exposure Therapy
16%
Potential Reservoir
16%
Macaque
16%
Experimental Vaccines
16%
Vaccine Research
16%
Gabon
16%
Republic of Congo
16%
Kikwit
16%
Fruit Bat
16%
Rapid Diagnostic Test
16%
Great Apes
16%
Insectivorous Bats
16%
Endangered Species
16%
Republic of Sudan
16%
Republic of Uganda
16%
Biochemistry, Genetics and Molecular Biology
Ebolavirus
100%
Marburgvirus
66%
Filovirus
50%
Infectious Agent
33%
Animal Model
16%
Clinical Trial
16%
Case Fatality Rate
16%
Macaca
16%
Filoviridae
16%
Immunology and Microbiology
Ebola Virus
100%
Marburgvirus
66%
Filovirus
50%
Infectious Agent
33%
Hemorrhagic Fever
16%
Immunology
16%
Case Fatality Rate
16%
Filoviridae
16%
Macaca
16%